User Tools

Site Tools


biomedin215-2011

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

biomedin215-2011 [2012/08/10 10:56]
nigam created
biomedin215-2011 [2012/08/10 10:57] (current)
nigam [Schedule and Syllabus]
Line 25: Line 25:
  
  
-^ Lecture^ Learning Objective^ Module^ Homework and Project^ Date^ HW Dataset^ 2012 Date+^ Lecture^ Learning Objective^ Module^ Homework and Project^ Date^ HW Dataset^ 
-| 1| Introduction,​ Overview and Relevance| Medical Dataminer'​s toolkit| {{:​fundamental.pdf|FS}},​ {{:​honorcode.pdf|HC}} |9/​27/​2011| ​|9/25/2012+| 1| Introduction,​ Overview and Relevance| Medical Dataminer'​s toolkit| {{:​fundamental.pdf|FS}},​ {{:​honorcode.pdf|HC}} |9/27/2011| | 
-| 2| Data mining in medicine -I | Medical Dataminer'​s toolkit| |9/​29/​2011| ​|9/27/2012+| 2| Data mining in medicine -I | Medical Dataminer'​s toolkit| |9/29/2011| | 
-| 3| Data mining in medicine - II | Medical Dataminer'​s toolkit| |10/​4/​2011| ​|10/2/2012+| 3| Data mining in medicine - II | Medical Dataminer'​s toolkit| |10/4/2011| | 
-| 4| Health Care Utilization Databases + Review of relevant Ontologies | Medical Dataminer'​s toolkit| |10/6/2011| AERS data|10/4/2012|+| 4| Health Care Utilization Databases + Review of relevant Ontologies | Medical Dataminer'​s toolkit| |10/6/2011| AERS data|
 ^ - ^ ^ ^ ^ ^ ^ ^ - ^ ^ ^ ^ ^ ^
-| 5| Introduction to Drug Safety Surveillance| Drug Safety Surveillance| HW-1 out|10/​11/​2011| ​|10/9/2012+| 5| Introduction to Drug Safety Surveillance| Drug Safety Surveillance| HW-1 out|10/​11/​2011| | 
-| 6| State of the art and Exemplar paper| Drug Safety Surveillance| |10/​13/​2011| ​|10/11/2012+| 6| State of the art and Exemplar paper| Drug Safety Surveillance| |10/​13/​2011| | 
-| 7| Other methods| Drug Safety Surveillance| |10/​18/​2011| ​|10/16/2012+| 7| Other methods| Drug Safety Surveillance| |10/​18/​2011| | 
-| 8| Other possible methods| Drug Safety Surveillance| |10/​20/​2011| ​|10/18/2012+| 8| Other possible methods| Drug Safety Surveillance| |10/​20/​2011| | 
-| 9| Project propsals| Drug Safety Surveillance| HW-1 due|10/​25/​2011| ​|10/23/2012|+| 9| Project propsals| Drug Safety Surveillance| HW-1 due|10/​25/​2011| |
 ^ - ^ ^ ^ ^ ^ ^ ^ - ^ ^ ^ ^ ^ ^
-| 10| Introduction to Predicting Readmissions | Predictive data-mining| |10/​27/​2011| ​|10/25/2012+| 10| Introduction to Predicting Readmissions | Predictive data-mining| |10/​27/​2011| | 
-| 11| State of the art (Readmissions) | Predictive data-mining|HW-2 out|11/​1/​2011| MIMIC II|10/30/2012+| 11| State of the art (Readmissions) | Predictive data-mining|HW-2 out|11/​1/​2011| MIMIC II| 
-| 12| Intro. to Co-morbidities and Exemplar paper (Discharge decision / Survival)| Predictive data-mining| |11/​3/​2011| ​|11/1/2012+| 12| Intro. to Co-morbidities and Exemplar paper (Discharge decision / Survival)| Predictive data-mining| |11/3/2011| | 
-| 13| State of the art (Discharge decision / Survival)| Predictive data-mining| |11/​8/​2011| ​|11/6/2012|+| 13| State of the art (Discharge decision / Survival)| Predictive data-mining| |11/8/2011| |
 ^ - ^ ^ ^ ^ ^ ^ ^ - ^ ^ ^ ^ ^ ^
-| 14| Clinical Text Mining: Goals and Key Problems| Clinical Text Mining| |11/​10/​2011| ​|11/8/2012+| 14| Clinical Text Mining: Goals and Key Problems| Clinical Text Mining| |11/​10/​2011| | 
-| 15| History and Review of the state of the art| Clinical Text Mining| HW-2 due, HW-3 out|11/​15/​2011| I2B2 data|11/13/2012+| 15| History and Review of the state of the art| Clinical Text Mining| HW-2 due, HW-3 out|11/​15/​2011| I2B2 data| 
-| 16| i2b2 NLP challenges| Clinical Text Mining| |11/​17/​2011| ​|11/15/2012+| 16| i2b2 NLP challenges| Clinical Text Mining| |11/​17/​2011| | 
-| 17| Non traditional approaches; How to improve on existing methods| Clinical Text Mining| HW-3 due |11/​29/​2011| ​|11/27/2012+| 17| Non traditional approaches; How to improve on existing methods| Clinical Text Mining| HW-3 due |11/​29/​2011| | 
-| 18| Wrap-up: What did we learn? What questions remain?​| ​ -  | |12/​1/​2011| ​|11/29/2012|+| 18| Wrap-up: What did we learn? What questions remain?​| ​ -  | |12/1/2011| |
 ^ - ^ ^ ^ ^ ^ ^ ^ - ^ ^ ^ ^ ^ ^
-| 19| PROJECT PRESENTATIONS| | Final Project|12/​6/​2011| ​|12/4/2012+| 19| PROJECT PRESENTATIONS| | Final Project|12/​6/​2011| | 
-| 20| PROJECT PRESENTATIONS| | Final Project|12/​8/​2011| ​|12/6/2012|+| 20| PROJECT PRESENTATIONS| | Final Project|12/​8/​2011| |
  
 ====== Useful References ====== ====== Useful References ======
biomedin215-2011.txt · Last modified: 2012/08/10 10:57 by nigam